| mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
| mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.05 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.05 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.05 |
| mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.05 |
| mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.062 |
0.05 |
| mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.05 |
| mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
| mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |